Advertisement
Advertisement
ELAN
Elanco Animal Health Incorporated Common Stock
23.65
USDSponsored
-0.36
-1.50%
May 08, 16:00 UTC -4
Closed
After-Market
23.30
-0.34
-1.46%
ELAN Earnings Reports
Positive Surprise Ratio
ELAN beat 26 of 31 last estimates.
84%
Next Report
Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
$1.35B
/$0.29
Implied change from Q1 26 (Revenue/ EPS)
-1.87%
/-27.50%
Implied change from Q2 25 (Revenue/ EPS)
+8.41%
/+11.54%
Elanco Animal Health Incorporated Common Stock earnings per share and revenue
On May 06, 2026, ELAN reported earnings of 0.40 USD per share (EPS) for Q1 26, beating the estimate of 0.35 USD, resulting in a 13.38% surprise. Revenue reached 1.37 billion, compared to an expected 1.31 billion, with a 4.39% difference. The market reacted with a +13.88% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 13 analysts forecast an EPS of 0.29 USD, with revenue projected to reach 1.35 billion USD, implying an decrease of -27.50% EPS, and decrease of -1.87% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Encompass Health Corporation Common Stock
Report Date
Apr 30, 2026 For Q1 26
Estimate
$1.51
Actual
$1.60
Surprise
+5.83%
DaVita Inc.
Report Date
May 05, 2026 For Q1 26
Estimate
$2.34
Actual
$2.87
Surprise
+22.59%
Option Care Health, Inc. Common Stock
Report Date
Apr 30, 2026 For Q1 26
Estimate
$0.37
Actual
$0.40
Surprise
+5.46%
LifeStance Health Group, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.00
Actual
$0.04
Surprise
+488.24%
Addus HomeCare Corp.
Report Date
May 04, 2026 For Q1 26
Estimate
$1.58
Actual
$1.62
Surprise
+2.42%
Astrana Health Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.30
Actual
$0.74
Surprise
+142.70%
US Physical Therapy Inc
Report Date
May 06, 2026 For Q1 26
Estimate
$0.55
Actual
$0.46
Surprise
-17.25%
The Pennant Group, Inc. Common Stock
Report Date
May 06, 2026 For Q1 26
Estimate
$0.31
Actual
$0.32
Surprise
+2.30%
FAQ
What were Elanco Animal Health Incorporated Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Elanco Animal Health Incorporated Common Stock reported EPS of $0.40, beating estimates by 13.38%, and revenue of $1.37B, 4.39% above expectations.
How did the market react to Elanco Animal Health Incorporated Common Stock's Q1 2026 earnings?
The stock price moved up 13.88%, changed from $22.99 before the earnings release to $26.18 the day after.
When is Elanco Animal Health Incorporated Common Stock expected to report next?
The next earning report is scheduled for Aug 05, 2026.
What are the forecasts for Elanco Animal Health Incorporated Common Stock's next earnings report?
Based on 13
analysts, Elanco Animal Health Incorporated Common Stock is expected to report EPS of $0.29 and revenue of $1.35B for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement